Plasma protein binding of ceftriaxone in critically ill patients: can we predict unbound fractions?

Ewoldt, Tim M J; Bahmany, Soma; Abdulla, Alan; Muller, Anouk E; Endeman, Henrik; Koch, Birgit C P

Ewoldt, Tim M J; Bahmany, Soma; Abdulla, Alan; Muller, Anouk E; Endeman, Henrik; Koch, Birgit C P.

Afiliación

Ewoldt TMJ; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
Bahmany S; Department of Intensive Care Medicine, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
Abdulla A; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands.
Muller AE; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
Endeman H; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
Koch BCP; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands.

J Antimicrob Chemother ; 78(4): 1059-1065, 2023 04 03.

Article en En | MEDLINE | ID: mdl-36849582

Asunto(s)

Ceftriaxona; Enfermedad Crítica; Humanos; Ceftriaxona/farmacocinética; Unión Proteica; Estudios Prospectivos; Cromatografía Liquida; Espectrometría de Masas en Tándem; Antibacterianos/uso terapéutico; Proteínas Sanguíneas/metabolismo; Albúminas/análisis; Albúminas/metabolismo

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ceftriaxona / Enfermedad Crítica Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Antimicrob Chemother Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google